Artículos de revistas sobre el tema "Measles virus, vaccine, humoral immune response, cellular immune response"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Measles virus, vaccine, humoral immune response, cellular immune response".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Lin, Wen-Hsuan, Chien-Hsiung Pan, Robert Adams, Brandi Ford, Beth Laube, John Mikszta, Vince Sullivan y Diane Griffin. "Route of immunization influences the induction of humoral, cellular and protective immunity by live attenuated measles vaccine in rhesus macaques (52.11)". Journal of Immunology 184, n.º 1_Supplement (1 de abril de 2010): 52.11. http://dx.doi.org/10.4049/jimmunol.184.supp.52.11.
Texto completoOvsyannikova, Inna G., Neelam Dhiman, Robert M. Jacobson, Robert A. Vierkant y Gregory A. Poland. "Frequency of Measles Virus-Specific CD4+ and CD8+ T Cells in Subjects Seronegative or Highly Seropositive for Measles Vaccine". Clinical Diagnostic Laboratory Immunology 10, n.º 3 (mayo de 2003): 411–16. http://dx.doi.org/10.1128/cdli.10.3.411-416.2003.
Texto completoToptygina, A. P., Yu Yu Andreev, M. A. Smerdova, A. Yu Zetkin y T. G. Klykova. "Formation of humoral and cellular immunity to measles vaccine in adults". Russian Journal of Infection and Immunity 10, n.º 1 (7 de abril de 2020): 137–44. http://dx.doi.org/10.15789/2220-7619-foh-1334.
Texto completoFitriah, Munawaroh y Jusak Nugraha. "Immunogenicity Assessment on Clinical Trials of SARS-CoV-2 Vaccines". INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY 28, n.º 2 (3 de junio de 2022): 202–8. http://dx.doi.org/10.24293/ijcpml.v28i2.1975.
Texto completoCZĘŚCIK, AGNIESZKA, MILENA DUNAL-SZCZEPANIAK, AGNIESZKA TRZCIŃSKA y JOANNA SIENNICKA. "Response of Viral Specific CD4 T Cells to in vitro Stimulation with Vaccine and Wild Measles Virus Strains in Vaccinated and Naturally Infected Subjects". Polish Journal of Microbiology 63, n.º 2 (2014): 203–9. http://dx.doi.org/10.33073/pjm-2014-026.
Texto completoGerna, Giuseppe, Chiara Fornara, Milena Furione y Daniele Lilleri. "Congenital Human Cytomegalovirus Infection: A Narrative Review of Maternal Immune Response and Diagnosis in View of the Development of a Vaccine and Prevention of Primary and Non-Primary Infections in Pregnancy". Microorganisms 9, n.º 8 (16 de agosto de 2021): 1749. http://dx.doi.org/10.3390/microorganisms9081749.
Texto completoWitkowski, Wojciech, Sarah Gerlo, Evelien De Smet, Magdalena Wejda, Delphine Acar, Steven Callens, Stefan Heytens et al. "Humoral and Cellular Responses to COVID-19 Vaccination Indicate the Need for Post-Vaccination Testing in Frail Population". Vaccines 10, n.º 2 (8 de febrero de 2022): 260. http://dx.doi.org/10.3390/vaccines10020260.
Texto completoOlszewska, Wieslawa, Charalambos D. Partidos y Michael W. Steward. "Antipeptide Antibody Responses following Intranasal Immunization: Effectiveness of Mucosal Adjuvants". Infection and Immunity 68, n.º 9 (1 de septiembre de 2000): 4923–29. http://dx.doi.org/10.1128/iai.68.9.4923-4929.2000.
Texto completoRodríguez Hernández, Carmen y Juan Carlos Sanz Moreno. "Immunity against SARS-CoV-2: walking to the vaccination". Revista Española de Quimioterapia 33, n.º 6 (11 de septiembre de 2020): 392–98. http://dx.doi.org/10.37201/req/086.2020.
Texto completoGracheva, Anastasiia V., Ekaterina R. Korchevaya, Roman V. Samoilikov, Daria I. Smirnova, Irina А. Leneva, Artem A. Poromov, Andrey А. Pankratov et al. "Аttenuation мarkers of cold-adapted SARS-CoV-2 variants". Medical academic journal 2, n.º 2 (6 de noviembre de 2022): 79–88. http://dx.doi.org/10.17816/maj108725.
Texto completoH.R., Teni, Wisnu Barlıanto, I. Wayan Arsana Wıyasa, H. M. S. Kusuma, Tita Sari y Novilia Bachtıar. "Analysis of specific antibody and cellular immune response to first-dose measles vaccine Edmonston-Zagreb (EZ) in 9-month-old infants". Allergologia et Immunopathologia 49, n.º 3 (1 de mayo de 2021): 193–201. http://dx.doi.org/10.15586/aei.v49i3.6.
Texto completoAl-Gburi, Sarah, Haidar Kadhim y Haider Ghazi. "Association of CD46 Cellular Receptor Gene SNP in Measles Vaccine Response". Iraqi Journal of Medical Sciences 18, n.º 1 (30 de junio de 2020): 39–46. http://dx.doi.org/10.22578/ijms.18.1.6.
Texto completoSmerdova, M. A., A. P. Toptygina, Yu Yu Andreev, S. V. Sennikova, A. Yu Zetkin, T. G. Klykova y S. I. Belyakov. "Humoral and cellular immunity to measles and rubella virus antigens in healthy subjects". Russian Journal of Infection and Immunity 9, n.º 3-4 (15 de noviembre de 2019): 607–11. http://dx.doi.org/10.15789/2220-7619-2019-3-4-607-611.
Texto completoLópez, Barriga, Lorente y Mir. "Immunoproteomic Lessons for Human Respiratory Syncytial Virus Vaccine Design". Journal of Clinical Medicine 8, n.º 4 (10 de abril de 2019): 486. http://dx.doi.org/10.3390/jcm8040486.
Texto completoHocknell, Peter K., Rebecca D. Wiley, Xiuqing Wang, Thomas G. Evans, William J. Bowers, Tomas Hanke, Howard J. Federoff y Stephen Dewhurst. "Expression of Human Immunodeficiency Virus Type 1 gp120 from Herpes Simplex Virus Type 1-Derived Amplicons Results in Potent, Specific, and Durable Cellular and Humoral Immune Responses". Journal of Virology 76, n.º 11 (1 de junio de 2002): 5565–80. http://dx.doi.org/10.1128/jvi.76.11.5565-5580.2002.
Texto completoSon, Wonrak, Nayoung Kim, Minhoon Lee, Euni Sim, Donghyun Song, Chiho Yu, YoungJo Song et al. "The effective immunization of plasmid DNA vaccine targeted for smallpox virus". Journal of Immunology 204, n.º 1_Supplement (1 de mayo de 2020): 167.32. http://dx.doi.org/10.4049/jimmunol.204.supp.167.32.
Texto completoLee, Min Ja, Hyundong Jo, So Hui Park, Mi-Kyeong Ko, Su-Mi Kim, Byounghan Kim y Jong-Hyeon Park. "Advanced Foot-And-Mouth Disease Vaccine Platform for Stimulation of Simultaneous Cellular and Humoral Immune Responses". Vaccines 8, n.º 2 (28 de mayo de 2020): 254. http://dx.doi.org/10.3390/vaccines8020254.
Texto completoKong, Wing-pui, Ling Xu, Konrad Stadler, Jeffrey B. Ulmer, Sergio Abrignani, Rino Rappuoli y Gary J. Nabel. "Modulation of the Immune Response to the Severe Acute Respiratory Syndrome Spike Glycoprotein by Gene-Based and Inactivated Virus Immunization". Journal of Virology 79, n.º 22 (15 de noviembre de 2005): 13915–23. http://dx.doi.org/10.1128/jvi.79.22.13915-13923.2005.
Texto completoStarostina, E. V., S. V. Sharabrin, A. P. Rudometov, V. R. Litvinova, M. B. Borgoyakova, S. I. Bazhan, A. A. Ilyichev y L. I. Karpenko. "Immune response against DNA- and mRNA vaccines encoding artificial influenza virus immunogens". Russian Journal of Immunology 25, n.º 3 (20 de septiembre de 2022): 321–26. http://dx.doi.org/10.46235/1028-7221-1103-ira.
Texto completoTornyos, G., Melinda Kovács, M. Rusvai, P. Horn, J. Fodor y F. Kovács. "Effect of dietary fumonisin b1 on certain immune parameters of weaned pigs". Acta Veterinaria Hungarica 51, n.º 2 (1 de marzo de 2003): 171–79. http://dx.doi.org/10.1556/avet.51.2003.2.5.
Texto completoLundstrom, Kenneth. "Self-Amplifying RNA Viruses as RNA Vaccines". International Journal of Molecular Sciences 21, n.º 14 (20 de julio de 2020): 5130. http://dx.doi.org/10.3390/ijms21145130.
Texto completoWang, Shen, Cheng Zhang, Bo Liang, Weiqi Wang, Na Feng, Yongkun Zhao, Tiecheng Wang et al. "Characterization of Immune Response Diversity in Rodents Vaccinated with a Vesicular Stomatitis Virus Vectored COVID-19 Vaccine". Viruses 14, n.º 6 (24 de mayo de 2022): 1127. http://dx.doi.org/10.3390/v14061127.
Texto completoMurtaza, Asad, Haroon Afzal, Thu-Dung Doan, Guan-Ming Ke y Li-Ting Cheng. "Flagellin Improves the Immune Response of an Infectious Bursal Disease Virus (IBDV) Subunit Vaccine". Vaccines 10, n.º 11 (22 de octubre de 2022): 1780. http://dx.doi.org/10.3390/vaccines10111780.
Texto completoChen, Keyan, Kui Zhao, Wenqi He, Wei Gao, Chuanbo Zhao, Li Wang, Wei Pan, Deguang Song, Chengli Wang y Feng Gao. "Comparative Evaluation of Two Hemagglutinating Encephalomyelitis Coronavirus Vaccine Candidates in Mice". Clinical and Vaccine Immunology 19, n.º 7 (18 de abril de 2012): 1102–9. http://dx.doi.org/10.1128/cvi.05716-12.
Texto completoPerciani, Catia T., Walter Jaoko, Sharon Walmsley, Bashir Farah, Salaheddin M. Mahmud, Mario Ostrowski, Omu Anzala, KAVI-ICR Team y Kelly S. MacDonald. "Protocol of a randomised controlled trial characterising the immune responses induced by varicella-zoster virus (VZV) vaccination in healthy Kenyan women: setting the stage for a potential VZV-based HIV vaccine". BMJ Open 7, n.º 9 (septiembre de 2017): e017391. http://dx.doi.org/10.1136/bmjopen-2017-017391.
Texto completoAberle, Judith H., Stephan W. Aberle, Regina M. Kofler y Christian W. Mandl. "Humoral and Cellular Immune Response to RNA Immunization with Flavivirus Replicons Derived from Tick-Borne Encephalitis Virus". Journal of Virology 79, n.º 24 (15 de diciembre de 2005): 15107–13. http://dx.doi.org/10.1128/jvi.79.24.15107-15113.2005.
Texto completoYan, Banadyga, Zhao, Zhao, Schiffman, Huang, Li et al. "Peste des Petits Ruminants Virus-Like Particles Induce a Potent Humoral and Cellular Immune Response in Goats". Viruses 11, n.º 10 (5 de octubre de 2019): 918. http://dx.doi.org/10.3390/v11100918.
Texto completoLi, Entao, Feihu Yan, Pei Huang, Hang Chi, Shengnan Xu, Guohua Li, Chuanyu Liu et al. "Characterization of the Immune Response of MERS-CoV Vaccine Candidates Derived from Two Different Vectors in Mice". Viruses 12, n.º 1 (20 de enero de 2020): 125. http://dx.doi.org/10.3390/v12010125.
Texto completoSultana, Sharmin, Shahina Tabassum, Afzalun Nessa y Munira Jahan. "Antibody Responses In Bangladeshi Children Following Measles Vaccination." Bangladesh Journal of Medical Microbiology 10, n.º 1 (13 de febrero de 2017): 13–17. http://dx.doi.org/10.3329/bjmm.v10i1.31447.
Texto completoJensen, Kara, Rafiq Nabi, Koen K. A. Van Rompay, Spencer Robichaux, Jeffrey D. Lifson, Michael Piatak, William R. Jacobs et al. "Vaccine-Elicited Mucosal and Systemic Antibody Responses Are Associated with Reduced Simian Immunodeficiency Viremia in Infant Rhesus Macaques". Journal of Virology 90, n.º 16 (1 de junio de 2016): 7285–302. http://dx.doi.org/10.1128/jvi.00481-16.
Texto completoQiao, Yongbo, Shuang Li, Shenghui Jin, Yi Pan, Yuhua Shi, Wei Kong y Yaming Shan. "A self-assembling nanoparticle vaccine targeting the conserved epitope of influenza virus hemagglutinin stem elicits a cross-protective immune response". Nanoscale 14, n.º 8 (2022): 3250–60. http://dx.doi.org/10.1039/d1nr08460g.
Texto completoBang, Yoo-Jin, Yun-Hee Kim, Yu-Sun Lee, Jae-Yong Kim, Hyo-Jung Park, Hae-Li Ko, Sang-In Park, Kyung-Ah Hwang, Hun Kim y Jae-Hwan Nam. "Development of inactivated subunit influenza vaccine endowing with IgA induction and protection against heterologous strain". Journal of Immunology 204, n.º 1_Supplement (1 de mayo de 2020): 245.11. http://dx.doi.org/10.4049/jimmunol.204.supp.245.11.
Texto completoMasalova, Olga V., Ekaterina I. Lesnova, Sergey M. Andreev, Nadezhda N. Shershakova, Vyacheslav V. Kozlov, Kristina Yu Permyakova, Natalia A. Demidova et al. "Adjuvant effect of dispersed fullerene C60 on the immune response to constructs harboring amino acid and nucleotide sequences of hepatitis C virus nonstructural NS5B protein". Problems of Virology 67, n.º 6 (7 de febrero de 2023): 516–26. http://dx.doi.org/10.36233/0507-4088-149.
Texto completoProbst, Peter, John B. Grigg, Emily A. Hemann, Yueh-Ming Loo, Megan L. Knoll, Renee Ireton, Michael J. Gale, Shawn P. Iadonato y Kristin M. Bedard. "Small molecule agonists of IRF3 activation function as influenza vaccine adjuvants by modulating the humoral and cellular anti-viral immune response". Journal of Immunology 196, n.º 1_Supplement (1 de mayo de 2016): 76.2. http://dx.doi.org/10.4049/jimmunol.196.supp.76.2.
Texto completoWalsh, E. E. "Humoral, Mucosal, and Cellular Immune Response to Topical Immunization with a Subunit Respiratory Syncytial Virus Vaccine". Journal of Infectious Diseases 170, n.º 2 (1 de agosto de 1994): 345–50. http://dx.doi.org/10.1093/infdis/170.2.345.
Texto completoJin, Yanwen, Cheng Cao, Ping Li, Xuan Liu, Wei Huang, Chufang Li y Qingjun Ma. "Boosting Immune Response to Hepatitis B DNA Vaccine by Coadministration of Prothymosin α-Expressing Plasmid". Clinical Diagnostic Laboratory Immunology 12, n.º 12 (diciembre de 2005): 1364–69. http://dx.doi.org/10.1128/cdli.12.12.1364-1369.2005.
Texto completoGrazhdantseva, A. A., D. V. Antonets, L. I. Karpenko, E. V. Starostina, M. B. Borgoyakova y G. V. Kochneva. "INDUCTION OF T-CELL IMMUNE RESPONSE BY A RECOMBINANT STRAIN OF VACCINIA VIRUS EXPRESSING A CASSETTE OF STRUCTURAL PROTEIN'S GENES OF MARBURG VIRUS". http://eng.biomos.ru/conference/articles.htm 1, n.º 19 (2021): 174–76. http://dx.doi.org/10.37747/2312-640x-2021-19-174-176.
Texto completoZhang, Xiao-Lian, Yushan Ren, Miao Lin y Yuanqin Min. "CpG-E1E2 glycosylation-mutants of Hepatitis C Virus enhance specific cellular immune response and neutralizing antibodes (113.14)". Journal of Immunology 188, n.º 1_Supplement (1 de mayo de 2012): 113.14. http://dx.doi.org/10.4049/jimmunol.188.supp.113.14.
Texto completoYu, Hong, Lorne A. Babiuk y Sylvia van Drunen Littel-van den Hurk. "Priming with CpG-enriched plasmid and boosting with protein formulated with CpG oligodeoxynucleotides and Quil A induces strong cellular and humoral immune responses to hepatitis C virus NS3". Journal of General Virology 85, n.º 6 (1 de junio de 2004): 1533–43. http://dx.doi.org/10.1099/vir.0.79821-0.
Texto completoHassett, Daniel E., Jie Zhang, Mark Slifka y J. Lindsay Whitton. "Immune Responses following Neonatal DNA Vaccination Are Long-Lived, Abundant, and Qualitatively Similar to Those Induced by Conventional Immunization". Journal of Virology 74, n.º 6 (15 de marzo de 2000): 2620–27. http://dx.doi.org/10.1128/jvi.74.6.2620-2627.2000.
Texto completoAtabani, Sowsan, Gary Landucci, Michael W. Steward, Hilton Whittle, Jeremiah G. Tilles y Donald N. Forthal. "Sex-Associated Differences in the Antibody-Dependent Cellular Cytotoxicity Antibody Response to Measles Vaccines". Clinical Diagnostic Laboratory Immunology 7, n.º 1 (1 de enero de 2000): 111–13. http://dx.doi.org/10.1128/cdli.7.1.111-113.2000.
Texto completoLukacs, Nicholas W. y Carrie-Anne Malinczak. "Harnessing Cellular Immunity for Vaccination against Respiratory Viruses". Vaccines 8, n.º 4 (21 de diciembre de 2020): 783. http://dx.doi.org/10.3390/vaccines8040783.
Texto completoLi, Hai, Hu Ren, Yangzi Zhou, Yan Zhang, Lei Cao y Wenbo Xu. "HRSV prefusion-F protein with Adju-Phos adjuvant induces long-lasting Th2-biased immunity in mice". PLOS ONE 17, n.º 1 (31 de enero de 2022): e0262231. http://dx.doi.org/10.1371/journal.pone.0262231.
Texto completoSpiri, Andrea M., Marilisa Novacco, Marina L. Meli, Martina Stirn, Barbara Riond, Jonathan E. Fogle, Felicitas S. Boretti, Imogen Herbert, Margaret J. Hosie y Regina Hofmann-Lehmann. "Modified-Live Feline Calicivirus Vaccination Elicits Cellular Immunity against a Current Feline Calicivirus Field Strain in an Experimental Feline Challenge Study". Viruses 13, n.º 9 (31 de agosto de 2021): 1736. http://dx.doi.org/10.3390/v13091736.
Texto completoWong, Pamela T., Peter H. Goff, Jessica J. O’Konek, Jeffrey J. Landers, Katarzyna W. Janczak, Pascale R. Leroueil, Peter Palese y James R. Baker. "Combined nanoemulsion and RIG-I agonist adjuvants-activation of diverse pathways for a broad spectrum influenza vaccine." Journal of Immunology 196, n.º 1_Supplement (1 de mayo de 2016): 145.11. http://dx.doi.org/10.4049/jimmunol.196.supp.145.11.
Texto completoDasari, Vijayendra, Corey Smith, Jie Zhong, Gillian Scott, William Rawlinson y Rajiv Khanna. "Recombinant glycoprotein B vaccine formulation with Toll-like receptor 9 agonist and immune-stimulating complex induces specific immunity against multiple strains of cytomegalovirus". Journal of General Virology 92, n.º 5 (1 de mayo de 2011): 1021–31. http://dx.doi.org/10.1099/vir.0.029413-0.
Texto completoPleyer, Christopher, Kerry J. Laing, Mir Ali, Christopher L. McClurkan, Susan Soto, Inhye E. Ahn, Pia Nierman et al. "Effect of Bruton Tyrosine Kinase Inhibitor on Serologic and Cellular Immune Responses to Recombinant Zoster Vaccine". Blood 138, Supplement 1 (5 de noviembre de 2021): 1556. http://dx.doi.org/10.1182/blood-2021-148539.
Texto completoHuang, Y., L. A. Babiuk y S. van Drunen Littel-van den Hurk. "Immunization with a bovine herpesvirus 1 glycoprotein B DNA vaccine induces cytotoxic T-lymphocyte responses in mice and cattle". Journal of General Virology 86, n.º 4 (1 de abril de 2005): 887–98. http://dx.doi.org/10.1099/vir.0.80533-0.
Texto completoLobby, Jenna L., Shamika Danzy, Anice Lowen y Jacob E. Kohlmeier. "Impact of pre-existing immunity on the development of de novo virus-specific TRM following live attenuated influenza vaccination". Journal of Immunology 208, n.º 1_Supplement (1 de mayo de 2022): 126.41. http://dx.doi.org/10.4049/jimmunol.208.supp.126.41.
Texto completoPogodina, E. A., A. V. Lobov, P. I. Ivanova, V. I. Kazey y I. Zh Shubina. "Induction of anti-SARS-CoV-2 immune reactions in immune compromised patients". Russian Journal of Biotherapy 20, n.º 4 (1 de diciembre de 2021): 18–25. http://dx.doi.org/10.17650/1726-9784-2021-20-4-18-25.
Texto completo